SIGA Technologies Inc. (SIGA) Earnings Call Analysis

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

15/25

Growth 2 Margin 4 Expansion 3 Platform 2 Financial 4

latest quarter score

Earnings Reports

15
SIGA (SIGA) Q2 2026: $13M International Expansion Signals Shift Amid U.S. Contract Delays
August 07, 2026
14
SIGA (SIGA) Q1 2026: $13M Asia-Pac Order Sets Up Q2 Revenue Surge Despite Lumpy Government Demand
May 08, 2026
12
SIGA (SIGA) Q3 2025: $26M Government Backlog Anchors 2026 Visibility Amid Procurement Delays
November 07, 2025
13
SIGA (SIGA) Q2 2025: $27M BARDA Development Funding Signals Broader U.S. Biodefense Commitment
August 06, 2025
15
SIGA (SIGA) Q1 2025: $70M U.S. Stockpile Orders Anchor Near-Term Visibility
July 05, 2025
15
SIGA (SIGA) Q1 2025: $26M IV TPOX Order Secures Multi-Year U.S. Stockpile Visibility
July 05, 2025
17
SIGA Technologies (SIGA) Q4 2024: $70M Pre-Tax Operating Income Reflects Resilient Smallpox Preparedness Leadership
March 11, 2025

Browse all companies